Cue Health deployed its rapid point-of-care diagnostic test for coronavirus disease 2019 (COVID-19) to Alaska, Florida, Louisiana, New Jersey, and Texas through a pilot program with the federal Department of Health and Human Services (HHS). The Cue Health test was used by the National Basketball Association (NBA) earlier in 2020 to screen basketball players.
The test uses nasal swabs and a cartridge-based reader that delivers results to a connected smartphone. For the pilot, the Cue Health test will be used for quick confirmatory testing of positives and suspicious negatives in high-concern populations and congregate care settings, such as nursing homes, long-term care, assisted living facilities, and veterans’ homes. The tests will also be used internally at the Department of Defense (DOD).
Cue Health Inc. is an ISO 13485-certified company founded by Ayub Khattak and Clint Sever focused on developing and manufacturing professional and consumer medical diagnostic products that can be used in clinical or at-home settings. Cue’s mission is to create tools that empower health care provider organizations and consumers by increasing their access to actionable health data. Cue’s first product, the Cue Health Monitoring System with the Cue COVID-19 Test Cartridge, is a platform that provides diagnostic information to clinical professionals and consumers seeking to benefit from a connected health care delivery ecosystem.
This was reported by Cue Health on November 19, 2020.
Contact information: Cue Health, 4980 Carroll Canyon Rd., Suite 100, San Diego, CA 92121; Website: https://www.cuehealth.com/
